Peng Tao, Wu Yang, Huang Li, He Bisong, Wei Shaobin
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shierqiao Road, Chengdu, Sichuan, China.
Medicine (Baltimore). 2021 Jan 29;100(4):e23916. doi: 10.1097/MD.0000000000023916.
Chronic pelvic pain (CPP) is one of the common sequela of pelvic inflammatory disease, the pathological factors are adhesions, scarring and pelvic congestion which caused by inflammation, often cause abdominal pain and lumbosacral soreness, and aggravated after fatigue, sexual intercourse and during menstruation. It is difficult to treat because special pathological changes. Although acupuncture has gained increased popularity for the management of CPP, evidence regarding its efficacy is lacking. Therefore, a systematic review of acupuncture for chronic pelvic pain in patients with SPID is required to provide available evidence for further study.
We will conduct a systematic review of randomized controlled trials (RCTs) that investigate the effect and safety of acupuncture for the treatment of chronic pelvic pain patients with SPID. We will electronically search the literature in the databases of PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, the Web of Science, China National Knowledge Infrastructure (CNKI), Wan-fang Digital Periodicals, Chinese Biomedical Literature Database (CBM), Chinese Scientific Journal Database (VIP) and select eligible articles. Data extraction will be conducted by 2 researchers independently, and risk of bias of the meta-analysis will be evaluated based on the Cochrane Handbook for Systematic Reviews of Interventions. The primary outcomes will be total effective rate and VAS pain score, and the secondary outcomes include the recurrence rate and adverse reaction. All data analysis will be conducted by software Review Manager V.5.3.
This study will provide the latest analysis of the currently available evidence for the efficacy of acupuncture for chronic pelvic pain in patients with SPID.
CRD42020193826.
慢性盆腔疼痛(CPP)是盆腔炎常见的后遗症之一,其病理因素为炎症导致的粘连、瘢痕形成和盆腔充血,常引起腹痛和腰骶部酸痛,劳累、性交及经期时加重。因其特殊的病理改变,治疗困难。尽管针刺疗法在慢性盆腔疼痛的治疗中越来越受欢迎,但关于其疗效的证据仍不足。因此,需要对针刺治疗盆腔炎后慢性盆腔疼痛进行系统评价,为进一步研究提供可用证据。
我们将对调查针刺治疗盆腔炎后慢性盆腔疼痛患者的疗效和安全性的随机对照试验(RCT)进行系统评价。我们将通过电子检索PubMed、Cochrane对照试验中心注册库(CENTRAL)、EMBASE、科学引文索引数据库、中国知网、万方数据期刊、中国生物医学文献数据库(CBM)、维普中文科技期刊数据库中的文献,并筛选合格的文章。由2名研究人员独立进行数据提取,并根据《Cochrane系统评价干预措施手册》评估荟萃分析的偏倚风险。主要结局指标为总有效率和视觉模拟评分法(VAS)疼痛评分,次要结局指标包括复发率和不良反应。所有数据分析将采用Review Manager V.5.3软件进行。
本研究将提供针刺治疗盆腔炎后慢性盆腔疼痛疗效的最新现有证据分析。
CRD42020193826。